Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Universiti Sains Malaysia Signs Sub Licence Agreement For Advancement Of Nanotechnology Platform With Biotechcorp

Abstract:
Technology transfer program signifies actual implementation of an academic, government agency and private sector partnership with Nanobiotix of France

Universiti Sains Malaysia Signs Sub Licence Agreement For Advancement Of Nanotechnology Platform With Biotechcorp

Malaysia and France | Posted on July 25th, 2008

Universiti Sains Malaysia (USM) signed a partnership agreement today on the Advancement of Nanotechnology Research and Collaboration with Malaysian Biotechnology Corporation (BiotechCorp). Based on the agreement, three USM researchers will undergo 12 months of training in France to intensify the R&D for the Malaysian biotechnology industry.

"USM has been chosen as our partner in this initiative, in line with its established track record in collaborative research work. It is very important for us to join forces with an institution of the highest standards in terms of expertise and professionalism. This is reflected in the partnership between BiotechCorp & USM to realize the objectives in the acquisition of the nanotechnology platform," said YBhg Dato' Iskandar Mizal Mahmood, the Chief Executive Officer of BiotechCorp.

At Bio San Diego 2008 earlier this month, BiotechCorp's international partners highlighted some important key actions to substantiate Malaysia's ambition to become a global biotechnology hub. One of the key actions suggested was the urgent need of an innovative programme to quickly expand or regain Malaysian talent in life sciences and biotechnology and to increase academic & private sector initiatives.

BiotechCorp was established on 13 May 2005 to ensure that the Government's biotechnology objectives and strategies are fully deployed. In 2007, BiotechCorp signed a technology transfer and license agreement with Nanobiotix S.A (NBTX) of France, where they acquired an exclusive worldwide license for a nanotechnology platform.

"We are pleased to commit to this agreement as this technology transfer programme will comprise technical information, know how, manufacturing techniques, engineering data, specifications of materials and other commercially privileged information proprietary to NBTX," said YBhg Professor Tan Sri Dato' Dzulkifli Abdul Razak, Vice-Chancellor of Universiti Sains Malaysia

The outcome of the training is for USM to develop a minimum of 2 new applications or products of substantial commercial value per year for a period of 4 years thus totaling 8 applications or products of substantial commercial value in 4 years. In return, all intellectual property rights to the improvements, enhancements, new inventions and innovations developed solely by USM shall be owned by USM.

"Collaboration of this nature does not work on a short-term basis. With this in mind, USM will ensure that within a period of not more than 12 months after the researchers return to Malaysia, a similar program will be conducted to enable other researchers to acquire the skills and knowledge earlier transmitted," added Tan Sri.

Furthermore, to add value to the technology transfer program, BiotechCorp will work alongside the three researchers to conduct seminars and road shows to create awareness on nanotechnology and its potential use with the aim to garner interest amongst the research community and encourage the uptake of sub-licenses among the research community.

USM will also map out a comprehensive plan for the training of other Malaysian researchers with an aim to cover all universities, research institutes and companies that are interested in utilizing the technology. The acquisition of this technology is also expected to provide a boost to USM's plans to develop its Science and Arts Innovation Space an integrated research and business development park that was announced recently.

####

Contacts:
YBhg Professor Tan Sri Dato' Dzulkifli Abdul Razak
Vice-Chancellor of Universiti Sains Malaysia

or
Professor Zainul F. Zainuddin
Director of USM's Innovation Office
or
Mobile Tel: +6012-9006730

Copyright © Universiti Sains Malaysia

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024

NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024

Innovative sensing platform unlocks ultrahigh sensitivity in conventional sensors: Lan Yang and her team have developed new plug-and-play hardware to dramatically enhance the sensitivity of optical sensors April 5th, 2024

Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024

Announcements

NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024

Innovative sensing platform unlocks ultrahigh sensitivity in conventional sensors: Lan Yang and her team have developed new plug-and-play hardware to dramatically enhance the sensitivity of optical sensors April 5th, 2024

Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024

A simple, inexpensive way to make carbon atoms bind together: A Scripps Research team uncovers a cost-effective method for producing quaternary carbon molecules, which are critical for drug development April 5th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Nanobiotechnology

New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024

Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Alliances/Trade associations/Partnerships/Distributorships

Manchester graphene spin-out signs $1billion game-changing deal to help tackle global sustainability challenges: Landmark deal for the commercialisation of graphene April 14th, 2023

Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project